This study will compare Dulce Digital (i.e., the investigators' proven-effective combination of "one-size-fits-all" educational text messages and nurse monitoring of patient-transmitted blood glucose values) and Dulce Digital-Me (DD-Me), an adaptive/dynamic mHealth (mobile health) intervention that is tailored to individuals' needs and behavioral progress, in improving diabetes clinical control, adherence, and patient-provider communication in Hispanics - an at-risk, understudied population that experiences disparities in diabetes prevalence and outcomes. These striking disparities in the growing and aging US Hispanic population have taxed the US healthcare system, while significantly reducing quantity and quality of life for millions of individuals. By offering an innovative, scalable, and sustainable approach that seamlessly integrates several mHealth technologies into existing primary care team processes to improve the health of Hispanics (and eventually, other at-risk, underserved groups), DD-Me has strong potential to significantly impact public health.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Glycosylated Hemoglobin (HbA1c) 6 Months After Enrollment
Timeframe: 6 months from baseline
Glycosylated Hemoglobin (HbA1c) 12 Months After Enrollment
Timeframe: 12 months from baseline
Low-density Lipoprotein-cholesterol (LDL-C); 6 Months After Enrollment
Timeframe: 6 months from baseline
Low-density Lipoprotein-cholesterol (LDL-C); 12 Months After Enrollment
Timeframe: 12 months from baseline
Systolic Blood Pressure (SBP); 6 Months From Enrollment
Timeframe: 6 months from baseline
Systolic Blood Pressure (SBP); 12 Months From Enrollment
Timeframe: 12 months from baseline